Risk Management Plans: the value of concomitant medication
OBJECTIVESA detailed knowledge of how a given medicine is used in real clinical practice is an important part of risk management plans. In addition to quantitative consumption data, a qualitative approach to know how a given medicine is, prescribed, administered or consumed. This course intends to widen this essential knowledge, and this including common co-medications.
LEARNING OUTCOMESAt the end of the course, you will be expert of the importance of know the most frequent medicines concomitantly used with the product of interest in risk management plans.
|
|
AUTHORS
Josep Maria Castel Universitat Autònoma de Barcelona |
Prof. Albert Figueras Consultant |
Roser Llop Universitat Autònoma de Barcelona |
Dr. Dolores Rodriguez Universitat Autònoma de Barcelona |